Toshimichi Onuma

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Endometrial Cancer

Epidermal Growth Factor Receptor

Top Venues

Healthcare (Basel, Switzerland)

The journal of obstetrics and gynaecology research

This page only lists publications with an associated author ORCID identifier.

Publications

Ito Taro, Toshimichi Onuma, Tetsuji Kurokawa, Yoko Chino, Akiko Shinagawa, Yoshio Yoshida
Evaluating Opt-In Vaginal Human Papillomavirus Self-Sampling: Participation Rates and Detection of High-Grade Lesions (CIN2+) among Unscreened Japanese Women Aged 30-39. Healthcare (Basel, Switzerland) 12 (5) (2024)
Toshimichi Onuma, Meshach Asare-Werehene, Yuko Fujita, Yoshio Yoshida, Benjamin K Tsang
Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer. Cells 13 (11) (2024)
Toshimichi Onuma, Akiko Shinagawa, Tetsuji Kurokawa, Makoto Orisaka, Yoshio Yoshida
Fractal Dimension, Circularity, and Solidity of Cell Clusters in Liquid-Based Endometrial Cytology Are Potentially Useful for Endometrial Cancer Detection and Prognosis Prediction. Cancers 16 (13) (2024)
Toshimichi Onuma, Meshach Asare-Werehene, Yuko Fujita, Yoshio Yoshida, Benjamin K Tsang
Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer. Cells 13 (11) (2024)
Toshimichi Onuma, Akiko Shinagawa, Tetsuji Kurokawa, Makoto Orisaka, Yoshio Yoshida
Fractal Dimension, Circularity, and Solidity of Cell Clusters in Liquid-Based Endometrial Cytology Are Potentially Useful for Endometrial Cancer Detection and Prognosis Prediction. Cancers 16 (13) (2024)
Shizuka Yamada, Makoto Orisaka, Tetsuji Kurokawa, Toshimichi Onuma, Akiko Shinagawa, Yoshio Yoshida
Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report. The journal of obstetrics and gynaecology research (2024)
Toshimichi Onuma, Meshach Asare-Werehene, Yuko Fujita, Yoshio Yoshida, Benjamin K Tsang
Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer. Cells 13 (11) (2024)
Ito Taro, Toshimichi Onuma, Tetsuji Kurokawa, Yoko Chino, Akiko Shinagawa, Yoshio Yoshida
Evaluating Opt-In Vaginal Human Papillomavirus Self-Sampling: Participation Rates and Detection of High-Grade Lesions (CIN2+) among Unscreened Japanese Women Aged 30-39. Healthcare (Basel, Switzerland) 12 (5) (2024)
Toshimichi Onuma, Meshach Asare-Werehene, Yoshio Yoshida, Benjamin K Tsang
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance. Cells 11 (20) (2022)
Toshimichi Onuma, Tetsuji Kurokawa, Akiko Shinagawa, Yoko Chino, Yoshio Yoshida
Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection. International journal of clinical oncology 25 (10) (2020)